Recent advances in the pharmacotherapy of cocaine dependence
- 1 September 2004
- journal article
- review article
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 6 (5) , 323-331
- https://doi.org/10.1007/s11920-004-0018-8
Abstract
The pharmacotherapy of cocaine dependence is a rapidly developing field of research that may soon produce efficacious medications. Expanding research on reward-related brain circuitry, which is acutely activated and chronically dysregulated by cocaine, has helped reveal the neurobiological features of cocaine dependence and is guiding pharmacologic strategies that have significant potential to improve clinical outcome. Cocaine dependence is a multifaceted disorder with distinct clinical components that may respond to different pharmacologic approaches. Pharmacologic strategies for this disorder include blocking euphoria, reducing withdrawal and negative mood symptoms, ameliorating craving, and enhancing the prefrontal cortical function that seems to be impaired in cocaine-dependent patients. One medication may not be sufficient to treat these diverse elements of cocaine dependence because preliminary studies report efficacy with medications that have opposite actions on reward-related circuits. This review highlights pertinent advances in cocaine neurobiology, recent clinical trials, and controversies in the pharmacologic treatment of cocaine dependence.Keywords
This publication has 84 references indexed in Scilit:
- Dopamine Neurons Mediate a Fast Excitatory Signal via Their Glutamatergic SynapsesJournal of Neuroscience, 2004
- Involvement of cholinergic neuronal systems in intravenous cocaine self-administrationNeuroscience & Biobehavioral Reviews, 2004
- Sexual Behavior and Sex-Associated Environmental Cues Activate the Mesolimbic System in Male RatsNeuropsychopharmacology, 2003
- Baclofen antagonizes nicotine‐, cocaine‐, and morphine‐induced dopamine release in the nucleus accumbens of ratSynapse, 2003
- New concepts in cocaine addiction: The dopamine depletion hypothesisPublished by Elsevier ,2003
- Effects of Mixed-Action κ/μ Opioids on Cocaine Self-Administration and Cocaine Discrimination by Rhesus MonkeysNeuropsychopharmacology, 2002
- The GABAB Receptor Agonist Baclofen Attenuates Cocaine- and Heroin-Seeking Behavior by RatsNeuropsychopharmacology, 2002
- A POTENTIAL ROLE FOR GABAB AGONISTS IN THE TREATMENT OF PSYCHOSTIMULANT ADDICTIONAlcohol and Alcoholism, 2002
- Neurobiological evidence for hedonic allostasis associated with escalating cocaine useNature Neuroscience, 2002
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001